These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 3900202)
1. G0 B cells activated by anti-mu acquire the ability to proliferate in response to B cell-activating factors independently from entry into G1 phase. Proust JJ; Chrest FJ; Buchholz MA; Nordin AA J Immunol; 1985 Nov; 135(5):3056-61. PubMed ID: 3900202 [TBL] [Abstract][Full Text] [Related]
2. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig. Muraguchi A; Kehrl JH; Butler JL; Fauci AS J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756 [TBL] [Abstract][Full Text] [Related]
4. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I. Kehrl JH; Muraguchi A; Fauci AS Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210 [TBL] [Abstract][Full Text] [Related]
5. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies. Maruyama S; Kubagawa H; Cooper MD J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101 [TBL] [Abstract][Full Text] [Related]
6. Proliferation of human malignant lymphocytes induced by anti-IgM independent of B cell growth factor. Baeker TR; Rothstein TL J Immunol; 1985 May; 134(5):3532-8. PubMed ID: 3872333 [TBL] [Abstract][Full Text] [Related]
7. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells. Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323 [TBL] [Abstract][Full Text] [Related]
8. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies. Cambier JC; Monroe JG J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706 [TBL] [Abstract][Full Text] [Related]
9. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. Phillips NE; Parker DC J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594 [TBL] [Abstract][Full Text] [Related]
10. Separate control of B lymphocyte early activation and proliferation in response to anti-IgM antibodies. DeFranco AL; Raveche ES; Paul WE J Immunol; 1985 Jul; 135(1):87-94. PubMed ID: 3873499 [TBL] [Abstract][Full Text] [Related]
11. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus. Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188 [TBL] [Abstract][Full Text] [Related]
12. LPS-activated CBA/N mouse B cells respond to anti-Ig and a BSF-1-like factor. Howard M; Pesavento P; Stein P J Immunol; 1986 Jun; 136(12):4531-7. PubMed ID: 3486901 [TBL] [Abstract][Full Text] [Related]
13. Functional properties of two human B cell growth factor species separated by lectin affinity column. Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105 [TBL] [Abstract][Full Text] [Related]
14. Differential activity of recombinant lymphokines on mouse B cell proliferation and cell cycle progression are revealed by 5-bromo-2'-deoxyuridine/Hoechst 33258 dye flow cytometry. Seyschab H; Hoehn H; Rabinovitch PS; Chen U Eur J Immunol; 1991 Sep; 21(9):2153-60. PubMed ID: 1909644 [TBL] [Abstract][Full Text] [Related]
15. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate. Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795 [TBL] [Abstract][Full Text] [Related]
16. B cells from M167 mu kappa transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. A model for antigen-induced B cell anergy. Sieckmann DG; Holmes K; Hornbeck P; Martin E; Guelde G; Bondada S; Longo DL; Kenny JJ J Immunol; 1994 May; 152(10):4873-83. PubMed ID: 8176209 [TBL] [Abstract][Full Text] [Related]
17. How relevant are growth and maturation factors to the B lymphocyte response induced by LPS? Inazawa M; Shiozawa C; Fotedar R; Diener E Lymphokine Res; 1985; 4(4):343-50. PubMed ID: 3876493 [TBL] [Abstract][Full Text] [Related]
18. Soluble factors involved in B cell differentiation: identification of two distinct T cell-replacing factors (TRF). Nakanishi K; Howard M; Muraguchi A; Farrar J; Takatsu K; Hamaoka T; Paul WE J Immunol; 1983 May; 130(5):2219-24. PubMed ID: 6601148 [TBL] [Abstract][Full Text] [Related]
19. Control of B cell proliferation: arrest of B cells in late G1 underlies immunosuppression induced by plasma cell tumors. Berman JE; Zolla-Pazner S J Immunol; 1987 May; 138(9):2805-12. PubMed ID: 3494771 [TBL] [Abstract][Full Text] [Related]
20. Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA. Thompson CB; Scher I; Schaefer ME; Lindsten T; Finkelman FD; Mond JJ J Immunol; 1984 Nov; 133(5):2333-42. PubMed ID: 6207226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]